Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Venture Funding Deals: From ADC To Y-mAbs, Capital Flows For New Platforms, Novel Approaches

Executive Summary

October was an active fundraising month for both start-up biopharma companies and more established privately held firms, ranging from $3m for Appili's drug for anaerobic infections to $270m for Harmony's rare disease programs.

Advertisement

Related Content

Finance Watch: NDA-Ready Impact Gets Commitment For Another $90m
Finance Watch: J&J Notes JLabs Incubators' Success Stories To Date
What Was On Hold Is New Again As Impact Raises $22.5m For Fedratinib
Harmony Biosciences Raises $270m; Acquires US Rights To Narcolepsy Drug
Cullinan To Search For Oncology’s Diamonds In The Rough

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099864

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel